CLINICAL_TRIALS
trial_result
· 2018-09-26
Clinical Trial Update: Inositol to Reduce Retinopathy of Prematurity [Phase 3]
Summary
Phase 3 trial evaluating inositol to reduce retinopathy of prematurity was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NICHD Neonatal Research Network | Conditions: Retinopathy of Prematurity (ROP) | Phase 3 | Status: TERMINATED | Results posted: 2018-09-26